Core Viewpoint - The company, Lihe Technology (Hunan) Co., Ltd., has announced its decision to exit its investment in Shanghai Survey and Design Research Institute Co., Ltd. through a capital reduction approach [1]. Investment Exit Situation - The company has decided to withdraw its investment in Shanghai Institute due to strategic adjustments in the latter's planning. This decision was made after comprehensive consideration [2]. - The company, as one of the shareholders of Shanghai Institute, has signed a "Capital Reduction Agreement" with other relevant parties. According to the agreement, Shanghai Institute will pay the company a capital reduction amount of 140.1067 million yuan via bank transfer. After the completion of this capital reduction, the company will no longer hold any equity in Shanghai Institute [2]. - The exit from the investment is based on the company's long-term development strategy and comprehensive considerations. It is stated that this decision will not have a significant impact on the company's business and operational development, nor will it adversely affect the company's financial status and operating results. There is no situation that harms the interests of the company and all shareholders, especially minority shareholders [2].

Core Viewpoint - The article discusses the upcoming IPO of Suzhou Lianxun Instrument Co., Ltd., which aims to raise approximately 1.711 billion yuan for various R&D projects in electronic measurement and semiconductor testing equipment [1]. Group 1: IPO Details - Lianxun Instrument plans to raise around 1.711 billion yuan through its IPO, with specific allocations for projects including 513 million yuan for next-generation optical communication testing equipment, 199 million yuan for automotive chip testing equipment, 385 million yuan for storage testing equipment, 304 million yuan for digital testing instruments, and 310 million yuan for the construction of a next-generation testing instrument R&D center [1]. - The company was established in 2017 with a registered capital of 77 million yuan, focusing on the R&D, manufacturing, sales, and service of electronic measurement instruments and semiconductor testing equipment [1]. Group 2: Company Background - The founder of Lianxun Instrument, Hu Haiyang, has a Ph.D. and extensive experience in the electronic measurement and semiconductor testing equipment industry, having worked for 15 years at Keysight Technologies, which originated from HP's electronic measurement division [2]. - Hu Haiyang transitioned to a marketing role at a newly established company before founding Lianxun Instrument, where he initially held a 55% stake through a proxy [2].

Core Viewpoint - The article discusses the acquisition of Tescan by Shimadzu Corporation, highlighting the strategic growth and transformation of Tescan under the ownership of Carlyle Group, which led to approximately 50% outperformance in market growth over three years [1][5]. Group 1: Acquisition Details - Carlyle Group announced the sale of Tescan, a leading manufacturer of electron microscopes, to Shimadzu Corporation for an enterprise value of $850 million [2][4]. - Tescan, established in 1991 and headquartered in Brno, Czech Republic, specializes in scanning electron microscopes, ion beam systems, and advanced scientific analysis instruments [4]. Group 2: Strategic Growth - Since acquiring Tescan in January 2023, Carlyle Group has facilitated a management transition and strategic repositioning focused on the rapidly growing semiconductor and nanotechnology markets [5]. - The three-pillar strategy executed by Carlyle and Tescan's management includes enhancing operational excellence, expanding market share through new product launches, and broadening target markets via product innovation and acquisitions [5]. Group 3: Leadership and Future Outlook - Key executives from Carlyle and Tescan expressed confidence in the company's transformation and its strengthened position in the semiconductor and nanotechnology markets, anticipating continued growth under Shimadzu's ownership [6]. - The complementary nature of Tescan's advanced imaging technologies with Shimadzu's product offerings is expected to enhance strategic expansion in high-growth analytical and semiconductor applications [6].

Core Viewpoint - The article discusses the launch of three specialized patent databases in Shanghai, aimed at enhancing innovation capabilities in agriculture, scientific instruments, and cell and gene therapy, thereby supporting the city's industrial development and intellectual property framework [1][2]. Group 1: Patent Database Overview - The three specialized patent databases focus on the following areas: - Modern Agriculture: Covers mechanization and intelligence, biotechnology and breeding, digital agriculture, and green low-carbon agriculture, with a total of 44 technical branches [2]. - Scientific Instruments and Research Reagents: Concentrates on high-purity and ultra-pure reagents, biological reagents, electronic chemicals, standard materials, supporting reagents, and functional reagents, encompassing 70 technical branches [2]. - Cell and Gene Therapy: Focuses on stem cell therapy, immune cell therapy, gene editing technology, RNA therapy, delivery vectors, and gene therapy drugs, with 50 technical branches [2]. Group 2: Services and Future Plans - The patent databases provide services such as visual data analysis, key patent collection, and full-text patent downloads, facilitating efficient use of patent information for researchers [2]. - The Shanghai Intellectual Property Service Center plans to continuously optimize database functions, expand data coverage, and enhance value-added services to convert patent data resources into real productivity, thereby injecting stronger momentum into Shanghai's industrial innovation and high-quality development [2][3].

Group 1 - The company Suzhou Su Shi Testing Group Co., Ltd. plans to invest at least 300 million yuan in a project to build and operate a high-end space environment simulation testing equipment and comprehensive testing service platform [1] - This project is part of the company's strategy to deepen its focus on testing equipment and services, continuing from its 2025 initiatives [1] - In the first half of 2025, the company completed the expansion of its Shenzhen laboratory to enhance its integrated circuit verification and analysis service capabilities in the Guangdong-Hong Kong-Macao Greater Bay Area [1] Group 2 - The company established an automotive electronics reliability verification center and is optimizing the capacity and technology of its integrated circuit laboratory [1] - The company has developed a thermal vacuum testing device that can simulate vacuum environments of 10⁻³Pa to 10⁻⁵Pa and above, suitable for space environment testing and reliability testing of various aerospace products [1]

Core Viewpoint - Beijing has introduced 14 policies aimed at enhancing the capacity of pilot testing services, with a goal to establish 10 national-level and 50 municipal-level pilot testing platforms by 2030, promoting the integration of technology and industry, and fostering new productive forces [1][4]. Background of Policy Issuance - Pilot testing is a transitional testing phase for new products moving towards production, crucial for the industrialization of technological achievements. Pilot testing platforms provide specialized services and systematic solutions to support the engineering breakthroughs and industrial applications of technological results [4]. Main Considerations of Measures - Beijing has made significant progress in integrating technological and industrial innovation, forming a "leading talent + new R&D institution" model. However, existing pilot testing platforms do not fully meet the demand for technological achievement transformation, leading to resource fragmentation. The new measures aim to address these issues through a combination of effective market and proactive government actions [6]. Specific Measures - The measures outline 14 policies focusing on four areas: layout of pilot testing platforms, continuous enhancement of service capabilities, optimization of the service ecosystem, and strengthening of support measures. The goal is to establish a pilot testing system that meets the requirements of the capital's modern industrial system by 2030 [7]. Key Initiatives - The measures emphasize the establishment of independent legal entities for pilot testing platforms, particularly in key industries such as artificial intelligence, healthcare, and green low-carbon technologies. New projects will receive financial support based on a percentage of total investment, with a maximum cap [8][9]. Enhancing Service Capabilities - The measures propose initiatives to improve the sustainability of pilot testing platforms, including open sharing of internal testing capabilities and enhancing full-chain service capabilities. This aims to expand the functions of pilot testing platforms to cover the entire industrial chain [10]. Optimizing the Service Ecosystem - The measures focus on strengthening the necessary support for pilot testing platforms, including space, information, finance, talent, and standards. They aim to build a collaborative pilot testing transformation base in the Beijing-Tianjin-Hebei region and enhance the matching of supply and demand through upgraded industrial mapping [11]. Implementation Organization - The measures call for coordinated efforts between city and district levels to ensure effective policy implementation. This includes leveraging the advantages of city-district collaboration and promoting the establishment of pilot testing service platforms in industrial clusters and parks [12].

摘要 ： 日前，海关总署2025年微波消解仪采购项目中标结果正式公布。上海新仪凭借其核心产品TANK 40微波消解仪脱颖而出，成功斩获30台采购订单，中标金额达313万元，成为本次招标的最大赢家。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 日前，海关总署2 0 2 5年微波消解仪采购项目中标结果正式公布。本次采购项目共计采购7 4台微 波消解仪，项目总金额达7 4 3 . 0 2万元。 上海新仪微波化学科技有限公司（ 以下简称"新仪"）凭借其核心产品 TANK 4 0微波消解仪 脱 颖而出， 成功斩获3 0台采购订单 ，中标金额达3 1 3万元 ，成为本次招标的最大赢家。 | 货物名称 | 货物品牌 | 货物型号 | 货物数量 | 货物单价（元） | | --- | --- | --- | --- | --- | | 微波消解仪C[配置1] | 上海新仪 | TANK 40 | 5 | 83800 | | 微波消解仪C[配置2] | 上海新仪 | TANK 40 | 15 | 97800 | | 微波消解仪C[配置3] | 上海新仪 ...

摘要 ： 浙江省公布2025年度首台（套）装备认定结果，微仪光电（浙江）有限公司"基于点扫描的高/超分辨显微成像系统"入选， 为国内首台（套）。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日，浙江省发布 首台（套）装备认定结果，其中， 微仪光电（浙江）有限公司 基于点扫描的高/超分辨显微成像系 统在列。 | | 装食 | 14.07 | | | | (云) | | --- | --- | --- | --- | --- | --- | --- | | 38 | 基于点扫描的高/超分 微仪光电(浙江) | | 湖州市 | 吴兴区 | 成套装备 | 国内首台 | | | 辨显微成像系统 | 有限公司 | | | | (皇 | | | | 士从此与到壮方阳 | | | | 同古古ム | 今年9月，浙江省机械工业联合会在浙江省湖州市组织召开了微仪光电(浙江)有限公司、微仪光电(天津)有限公司、深 圳 大 学 等 单 位 开 发 的 " 基 于 点 扫 描 的 高 / 超 分 辨 显 微 成 像 系 统 " 项 目 的 科 技 成 果 鉴 定 ...

近日 ，罗氏诊断中国宣布，其备受瞩目的 国产全自动核酸提取及荧光 PCR 检测系统c oba s ® 5 8 0 0 正式获得国家药品监督管理局（ NMPA ）批准，被授予 三类医疗器械注册证 ，开拓分子诊断领域 " 中国智造 " 荣耀新局，加速赋能精准诊疗。 姚国樑 罗氏诊断中国总经理 创新和质量是罗氏诊断的核心基因，而 '中国智造'则是我们将前沿创新、高质量成果惠及广大中国患者的关键引擎。作为罗氏诊断在分 子诊断领域的集大成之作， c o b a s ® 5 8 0 0 于 2 0 2 3年进入中国市场，如今成功实现了国产化飞跃，不仅充分印证了罗氏诊断'在中 国，为中国'的坚定承诺和信心，更标志着我们在深化本地价值链布局上迈出的坚实一步。未来，罗氏诊断将继续以创新驱动发展， 以品质铸就信任，加速更多全球顶尖诊断技术在华落地生根。 方寸乾坤，灵动智慧 引领分子诊断新未来 新时代精准医疗背景下，分子诊断在感染性疾病、血液安全、女性健康等领域展现出前所未有的应用价值。然而，面对日益增长的检测需求与 有限的实验室空间及人力资源之间的矛盾，如何在保证检测质量的同时提升效率，成为众多医疗机构面临的关键挑战。 此次实现 ...

摘要 ： 浙江布瑞利斯完成数千万元Pre-A轮融资，由远毅资本领投，资金将用于技术迭代、市场拓展与 产能升级，推动连续流+光化学装备智能化、绿色化发展。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 浙 江 布 瑞 利 斯 科 技 有 限 公 司 作 为 国 内 连 续 流 + 光 化 学 装 备 与 工 艺 解 决 方 案 领 域 的 创 新 型 企 业，近日已完成数千万元Pre-A轮融资。本次融资由深耕数字医疗领域的远毅资本领投，东方 产融旗下象海产融基金跟投，青桐资本作为本次财务顾问。此次融资不仅是我司发展历程中的 重要里程碑，更彰显了资本市场对其在连续流及光化学装备智能化、绿色化赛道技术实力与商 业化潜力的高度认可。 关于浙江布瑞利斯科技有限公司 | 版 权 ： 本 文 部 分 素 材 源 自 网 络 ， 版 权 归 原 作 者 所 有 ， 观 点 代 表 作 者 本 人 ， 不 代 表 本 号 立 场 发 文 不 易 ， 请 帮 小 编 点 下 "❤️" ↓ | 转 载 ： 须 本 号 授 权 ， 请 联 系 主 编 | 来 ...